The latest closing stock price for Rapt Therapeutics as of November 20, 2024 is 1.07.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-916 today, roughly -1 times their original investment - a -39.03% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 27.35, which is 2456.1% above the current share price.
The Rapt Therapeutics 52-week low stock price is 1.01, which is 5.6% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 8.52.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-916 today, roughly -1 times their original investment - a -39.03% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 27.35, which is 2456.1% above the current share price.
The Rapt Therapeutics 52-week low stock price is 1.01, which is 5.6% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 8.52.